MedTrace Logo

Effect Evaluation of Independent Medical Evaluation (IME) in Norway

NCT02524392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7642

Last updated 2018-05-11

No results posted yet for this study

Summary

A randomized controlled trial comparing independent medical evaluation (IME) to treatment as usual (TAU). Participants will be individuals reaching six months uninterrupted sickness absence. Treatment as usual (TAU) is normal follow-up by a general practitioner (GP).

Conditions

  • All International Classification of Primary Care 2 Diagnoses

Interventions

OTHER

Independent medical evaluation

The independent medical evaluation (IME) will be performed by specialists in general medicine, temporarily hired by the county welfare service. The independent medical evaluation (IME) procedure is developed by the Research Unit for General Practice at Uni Research Health in Norway.

Sponsors & Collaborators

  • Norwegian Labour and Welfare Administration

    collaborator OTHER

  • NORCE Norwegian Research Centre AS

    lead OTHER

Principal Investigators

  • Silje Maeland, PhD · Uni Research Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
66 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-02-28
Completion
2018-03-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02524392 on ClinicalTrials.gov